Sodium molybdate

Reported in EPA TSCA Inventory.

OSHA PEL: TWA 5 mg(Mo)/m³
ACGIH TLV: TWA Soluble Compounds: TWA 0.5 mg(Mo)/m³ Confirmed Animal Carcinogen with Unknown Relevance to Humans

The Disodium molybdate, with the CAS registry number 7631-95-0, is also known as Molybdic acid (H₂MoO₄) , disodium salt. It belongs to the product categories of Inorganic & Organic Chemicals; Inorganic Chemicals; Inorganics; Catalysis and Inorganic Chemistry; Chemical Synthesis; Molybdenum. Its EINECS registry number is 231-551-7. This chemical's molecular formula is MoNa₂O₄ and molecular weight is 205.92. Its IUPAC name is called disodium dioxido(dioxo)molybdenum. This chemical's classification codes are Mutation data; Reproductive Effect.

Physical properties of Disodium molybdate: (1)H-Bond Donor: 0; (2)H-Bond Acceptor: 4; (3)Rotatable Bond Count: 0; (4)Exact Mass: 207.864606; (5)MonoIsotopic Mass: 207.864606; (6)Topological Polar Surface Area: 80.3; (7)Heavy Atom Count: 7; (8)Formal Charge: 0; (9)Complexity: 62.2; (10)Covalently-Bonded Unit Count: 3.

Preparation: this chemical can be prepared by molybdenum trioxide and sodium carbonate.

Uses of Disodium molybdate: this chemical can be used for the preparation of molybdenum salt and dyes, pigments, catalyst, corrosion inhibitor, etc. Besides, it also can be used for metal corrosion inhibitor, except furring agent, bleaching agent and promote skin and hair ulcer.

When you are using this chemical, please be cautious about it as the following:
This chemical may cause inflammation to the skin or other mucous membranes. It is irritating to eyes, respiratory system and skin. In case of contact with eyes, you should rinse immediately with plenty of water and seek medical advice. Whenever you will contact it, please wear suitable protective clothing.

You can still convert the following datas into molecular structure:
(1)Canonical SMILES: [O-][Mo](=O)(=O)[O-].[Na+].[Na+]
(2)InChI: InChI=1S/Mo.2Na.4O/q;2*+1;;;2*-1
(3)InChIKey: TVXXNOYZHKPKGW-UHFFFAOYSA-N

The toxicity data is as follows:

Organism	Test Type	Route	Reported Dose (Normalized Dose)	Effect	Source
cat	LD50	intravenous	917mg/kg (917mg/kg)	VASCULAR: BP LOWERING NOT CHARACTERIZED IN AUTONOMIC SECTION LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION	Agressologie. Revue Internationale de Physio-Biologie et de Pharmacologie Appliquees aux Effets de l'Agression. Vol. 8, Pg. 51, 1967.
mouse	LD50	intraperitoneal	303mg/kg (303mg/kg)		Environmental Quality and Safety, Supplement. Vol. 1, Pg. 1, 1975.
mouse	LD50	subcutaneous	570mg/kg (570mg/kg)		Naunyn-Schmiedeberg's Archiv fuer Experimentelle Pathologie und Pharmakologie. Vol. 244, Pg. 17, 1962.
rat	LC50	inhalation	> 2080mg/m3/4H (2080mg/m3)		Cyprus Copper Company. Vol. 18JUN1991,
rat	LD50	intraperitoneal	576mg/kg (576mg/kg)		Environmental Quality and Safety, Supplement. Vol. 1, Pg. 1, 1975.
rat	LD50	oral	4gm/kg (4000mg/kg)		Cyprus Copper Company. Vol. 18JUN1991,